TransMedics Group, Inc. - 8-K Filing
TransMedics Group held its annual shareholder meeting on May 20, 2026, where shareholders elected eight directors and approved executive compensation and an amendment to the 2019 Stock Incentive Plan. The plan was amended to increase share reserves from 5,390,502 to include up to 5,424,072 shares for ISOs, extend its term until June 1, 2036, and adjust vesting rules requiring a minimum one-year vesting period starting January 1, 2027. The amendment also revised provisions related to covered transactions. (Items: 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $TMDX